Zixi Zhang
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Homoharringtonine Impedes Migration and Invasion by Inhibiting EphB4/SRI/EMT Signaling and Enhances the Antimetastatic Abilities of Erlotinib in Pancreatic Cancer.
Journal: Current cancer drug targets
Published: July 25, 2025
Identification of RCC2 as a Risk Gene Associated With Basal Cell Carcinoma and Experimental Validation.
Journal: Experimental dermatology
Published: August 27, 2024
Identification of hub gene associated with colorectal cancer: Integrating Mendelian randomization, transcriptome analysis and experimental verification.
Journal: PLoS genetics
Published: July 03, 2024
Cantharidin overcomes IL-2Rα signaling-mediated vorinostat resistance in cutaneous T-cell lymphoma through reactive oxygen species.
Journal: Journal for immunotherapy of cancer
Published: June 21, 2024
Notch-Targeted Therapeutic in Colorectal Cancer by Notch1 Attenuation Via Tumor Microenvironment-Responsive Cascade DNA Delivery.
Journal: Advanced healthcare materials
Published: February 29, 2024
Sex-specific differences in the effect of lymphocyte-to-C-reactive protein ratio on subclinical myocardial injury in the general population free from cardiovascular disease.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: June 01, 2023
The prognostic impact of BMI on colorectal cancer is stratified by tumor location.
Journal: Frontiers in oncology
Published: July 06, 2022
Porphyrin-Based Multicomponent Metallacage: Host-Guest Complexation toward Photooxidation-Triggered Reversible Encapsulation and Release.
Journal: JACS Au
Published: April 20, 2022
Water-soluble thienoviologen derivatives for imaging bacteria and antimicrobial photodynamic therapy.
Journal: Journal of materials chemistry. B
Published: March 28, 2022
Robust hydrogel adhesives for emergency rescue and gastric perforation repair.
Journal: Bioactive materials
Published: January 09, 2022
Delta-like ligand 4 level in colorectal cancer is associated with tumor aggressiveness and clinical outcome.
Journal: Cancer biomarkers : section A of Disease markers
Published: September 06, 2021
Last Updated: 09/26/2026